Improved Access to Care for Primary Immunodeficiency Patients
This act aims to improve access for primary immunodeficiency patients to skilled nursing facilities, especially for intravenous medication administration. This will allow these individuals to receive necessary treatment in appropriate settings, enhancing their comfort and quality of life. The changes will take effect on January 1, 2024.
Key points
Primary immunodeficiency patients will gain better access to skilled nursing facilities for intravenous medication administration.
The act ensures that the costs of administering intravenous immune globulin will be covered within skilled nursing facility care.
The changes will become effective on January 1, 2024, meaning patients can benefit from the new rules from that date.
Expired
Citizen Poll